<DOC>
	<DOCNO>NCT00863980</DOCNO>
	<brief_summary>This study aim investigate whether treatment Telmisartan effective Candesartan reduce ischemic cardiovascular event high-risk patient cardiovascular disease .</brief_summary>
	<brief_title>Effects Telmisartan Ischemic Cardiovascular Events High-risk Hypertensive Patients</brief_title>
	<detailed_description>This study aim investigate whether treatment Telmisartan effective Candesartan reduce ischemic cardiovascular event high-risk patient cardiovascular disease . Study design : PROBE ( Prospective , Randomized , Open-labeled Blind Endpoints )</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>The inclusion criterion set least one three follow risk factor : 1 . Coronary artery disease document least one following : Myocardial infarction least 12 month enrollment plan percutaneous coronary intervention ( PCI ) coronary artery bypass grafting ( CABG ) Angina pectoris asymptomatic myocardial ischemia undergo percutaneous coronary intervention ( PCI ) coronary artery bypass grafting ( CABG ) least 12 month enrollment plan percutaneous coronary intervention ( PCI ) coronary artery bypass grafting ( CABG ) 2 . Peripheral arterial disease undergo percutaneous transluminal angioplasty ( PTA ) peripheral artery bypass graft least 6 month enrollment 3 . Symptomatic cerebral infarction cerebral hemorrhage least 6 month enrollment The exclusion criterion set follow : 1 . History worsen heart failure within precede 6 month 2 . Planned elective percutaneous coronary intervention ( PCI ) coronary artery bypass grafting ( CABG ) within antecede 3 month 3 . History myocardial infarction , unstable angina pectoris , percutaneous coronary intervention ( PCI ) coronary artery bypass grafting ( CABG ) within precede 12 month 4 . History percutaneous hind limb angioplasty ( PTA ) bypass graft within precede 6 month 5 . History cerebral infarction , cerebral hemorrhage within past 6 month 6 . Congenital heart disease 7 . Uncontrolled hypertension treatment ( eg , BP &gt; 180/110 mmHg ) 8 . Pregnant woman woman childbearing potential 9 . Hepatic dysfunction ( AST ALT &gt; 100IU/L ) 10 . Renal impairment ( serum creatinine level &gt; 2.0 mg per 100 ml ) 11 . Known hypersensitivity intolerance ARB</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>angiotensin</keyword>
	<keyword>receptor</keyword>
	<keyword>vulnerable plaque</keyword>
	<keyword>coronary artery</keyword>
</DOC>